Literature DB >> 30478618

Different routes of heroin intake cause various heroin-induced leukoencephalopathies.

Mei-Yun Cheng1,2,3, Shy-Chyi Chin4, Yen-Chung Chang3,5, Tony Wu1,2, Siew-Na Lim1,2, Hsiang-Yao Hsieh1,2, Jung-Lung Hsu2,6, Chun-Wei Chang1,2, Wei-En Johnny Tseng1,2, Han-Tao Li1,2, Hsing-I Chiang1,2, Bao-Luen Chang1,2, Meng-Han Tsai7, Long-Sun Ro8,9.   

Abstract

OBJECTIVE: Toxic leukoencephalopathy is a rare but critical neurological disorder in heroin abusers. Our aim is to compare the clinical manifestations, brain MRIs and prognoses of heroin-induced leukoencephalopathy by different intake routes.
METHODS: We present two patients with toxic leukoencephalopathy caused by intravenous (IV) injection of heroin and 48 additional cases from systematic reviews of the literature published between 1994 and 2018.
RESULTS: Among the 50 heroin abusers who developed leukoencephalopathy, inhalation was the most popular route (60%), followed by IV injection (30%) and snorting (10%). Mental changes, mutism and urine/fecal incontinence were the major symptoms in patients who IV injected heroin, while cerebellar ataxia and dysarthria were more common among those who inhaled heroin. Delayed-onset encephalopathy uniquely occurred in those who IV injected heroin, whereas progressive encephalopathy was more commonly observed in those who inhaled heroin. Clinical improvement was observed in 60% of patients, the overall mortality rate was 12%, and higher mortality was observed in patients who used the inhalation route (16.7%). The hallmarks on the MRIs of those who inhaled heroin were posterior to anterior involvement of the cerebral white matter and lesions in the posterior limbs of the internal capsules, cerebellum and brainstem. In contrast, those who IV injected heroin had more frequent lesions in the subcortical U fibers and the genu of the internal capsules.
CONCLUSION: These data could help physicians make an early diagnosis and predict prognosis and suggest that prompt antioxidative or symptomatic treatments might reduce the long-term consequences and mortality of heroin-induced leukoencephalopathy.

Entities:  

Keywords:  Heroin; Inhalation; Intravenous; Leukoencephalopathy; MRI; Snorting

Mesh:

Substances:

Year:  2018        PMID: 30478618     DOI: 10.1007/s00415-018-9131-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

Review 1.  Toxic and metabolic leukoencephalopathies in emergency department patients: a primer for the radiologist.

Authors:  Neal R Shah; Shahrzad Tavana; Akwasi Opoku; Douglas Martin
Journal:  Emerg Radiol       Date:  2022-02-24

2.  A vapor exposure method for delivering heroin alters nociception, body temperature and spontaneous activity in female and male rats.

Authors:  Arnold Gutierrez; Kevin M Creehan; Michael A Taffe
Journal:  J Neurosci Methods       Date:  2020-10-30       Impact factor: 2.390

Review 3.  "CHOICES": An acronym to aid in delineating potential causes of non-metabolic, non-infectious acute toxic leukoencephalopathy.

Authors:  Yasemin Koksel; Can Ozutemiz; Jeffrey Rykken; Frederick Ott; Zuzan Cayci; Mark Oswood; Alexander M McKinney
Journal:  Eur J Radiol Open       Date:  2019-06-28

4.  Heroin-Induced Leukoencephalopathy.

Authors:  Mohsen S Alshamam; Vikram Sumbly; Nso Nso; Merjona Saliaj; Dawa O Gurung
Journal:  Cureus       Date:  2021-02-03

5.  Leukoencephalopathy due to inhalational and trans-conjunctival heroin abuse: First case report from Pakistan.

Authors:  Mohammad Suleman Bajwa; Hassan Nawaz; Muhammad Aemaz Ur Rehman; Sadaf Iftikhar; Abu Hurera
Journal:  Ann Med Surg (Lond)       Date:  2022-02-05

6.  Bilateral middle cerebellar peduncle lesions: Neuroimaging features and differential diagnoses.

Authors:  Jiwei Jiang; Jirui Wang; Meiqing Lin; Xiaoting Wang; Jinli Zhao; Xiuli Shang
Journal:  Brain Behav       Date:  2020-08-05       Impact factor: 2.708

Review 7.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.